Atea Pharmaceuticals
AVIR
#7528
Rank
HK$2.21 B
Marketcap
HK$26.23
Share price
3.69%
Change (1 day)
18.03%
Change (1 year)

Earnings for Atea Pharmaceuticals (AVIR)

Earnings in 2024 (TTM): -HK$1.37 Billion

According to Atea Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$1.06 Billion a decrease over its 2022 earnings that were of -HK$0.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atea Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$1.37 Billion30.25%
2023 -HK$1.06 Billion12.92%
2022 -HK$0.94 Billion-186.22%
2021 HK$1.07 B-1366.01%
2020 -HK$85.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.98 Billion-28.49%๐Ÿ‡บ๐Ÿ‡ธ USA